Literature DB >> 24888281

Sodium administration in critically ill paediatric patients in Australia and New Zealand: a multicentre point prevalence study.

Shailesh Bihari1, Marino Festa2, Sandra L Peake3, Ian M Seppelt4, Patricia Williams3, Barry Wilkins5, Andrew Bersten6.   

Abstract

OBJECTIVE: Dysnatraemia and a positive fluid balance are associated with poor outcomes in paediatric intensive care units (PICUs). Our objective was to determine sodium intake and the total daily fluid balance in children in the PICU.
METHOD: A single-day point prevalence study in 10 Australian and New Zealand PICUs. Patients on free oral diets were excluded. Demographics, 24-hour fluid balance and sodium intake (enteral and parenteral sources) were recorded.
RESULTS: We enrolled 65 patients; 15 were excluded due to having a free oral intake and two patients had incomplete data, leaving 48 children in the study cohort. The 21 infants had a median age of 4 months (interquartile range [IQR], 1-7 months) and a median bodyweight of 5 kg (IQR, 3.5- 6.1 kg). The 27 children > 1 year had a median age of 3 years (IQR, 1.5-13 years) and a median bodyweight of 17 kg (IQR, 9.5-47.5 kg). Overall, the median sodium administration on the study day was 4.9mmol/kg (IQR, 3.2- 8mmol/kg), median fluid administration was 80.8mL/kg (IQR, 49.8-111.4mL/kg) and median fluid balance was 9mL/kg (IQR, -1.4 to 41 mL/kg). For infants, the median sodium administration was 6mmol/kg (IQR, 3.9-8.1mmol/ kg), and median fluid balance was 20.8mL/kg (IQR, 3.5- 47.2mL/kg). For children > 1 year, the median sodium administration was 3.5mmol/kg (IQR, 3.1-7.8mmol/kg), and median fluid balance was 5.3mL/kg (IQR, -2.7 to 17.7mL/kg). Overall, fluid infusions, boluses and catheter flushes together contributed 46.2% of total sodium administered. Drugs contributed substantially to administered sodium (33.3%), with antibiotics accounting for the majority. Enteral feeds contributed 16.2% to overall administered sodium, and were the major source in patients in the PICU for > 10 days.
CONCLUSION: Daily sodium intake in children in the PICU is high. The contributions of maintenance and bolus intravenous fluids (most commonly as 0.9% sodium chloride), drug infusions and boluses, including antibiotics, and enteral feeds, are significant.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24888281

Source DB:  PubMed          Journal:  Crit Care Resusc        ISSN: 1441-2772            Impact factor:   2.159


  4 in total

1.  Chloride-liberal vs. chloride-restrictive intravenous fluid administration and acute kidney injury: an extended analysis.

Authors:  Nor'azim Mohd Yunos; Rinaldo Bellomo; Neil Glassford; Harvey Sutcliffe; Que Lam; Michael Bailey
Journal:  Intensive Care Med       Date:  2014-12-18       Impact factor: 17.440

Review 2.  Fluid-induced harm in the hospital: look beyond volume and start considering sodium. From physiology towards recommendations for daily practice in hospitalized adults.

Authors:  Niels Van Regenmortel; Lynn Moers; Thomas Langer; Ella Roelant; Tim De Weerdt; Pietro Caironi; Manu L N G Malbrain; Paul Elbers; Tim Van den Wyngaert; Philippe G Jorens
Journal:  Ann Intensive Care       Date:  2021-05-17       Impact factor: 6.925

3.  Maintenance fluid therapy and fluid creep impose more significant fluid, sodium, and chloride burdens than resuscitation fluids in critically ill patients: a retrospective study in a tertiary mixed ICU population.

Authors:  Niels Van Regenmortel; Walter Verbrugghe; Ella Roelant; Tim Van den Wyngaert; Philippe G Jorens
Journal:  Intensive Care Med       Date:  2018-03-27       Impact factor: 17.440

4.  Fluid therapy in mechanically ventilated critically ill children: the sodium, chloride and water burden of fluid creep.

Authors:  Thomas Langer; Veronica D'Oria; Giulia C I Spolidoro; Giovanna Chidini; Stefano Scalia Catenacci; Tiziana Marchesi; Marta Guerrini; Andrea Cislaghi; Carlo Agostoni; Antonio Pesenti; Edoardo Calderini
Journal:  BMC Pediatr       Date:  2020-09-05       Impact factor: 2.125

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.